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Anovulation is a major cause of infertility, and it is the major leading reproductive disorder
in mammalian females. Without ovulation, an oocyte is not released from the ovarian
follicle to be fertilized and a corpus luteum is not formed. The corpus luteum formed
from the luteinized somatic follicular cells following ovulation, vasculature cells, and
immune cells is critical for progesterone production and maintenance of pregnancy.
Follicular theca cells differentiate into small luteal cells (SLCs) that produce progesterone
in response to luteinizing hormone (LH), and granulosa cells luteinize to become large
luteal cells (LLCs) that have a high rate of basal production of progesterone. The formation
and function of the corpus luteum rely on the appropriate proliferation and differentiation
of both granulosa and theca cells. If any aspect of granulosa or theca cell luteinization
is perturbed, then the resulting luteal cell populations (SLC, LLC, vascular, and immune
cells) may be reduced and compromise progesterone production. Thus, many factors
that affect the differentiation/lineage of the somatic cells and their gene expression profiles
can alter the ability of a corpus luteum to produce the progesterone critical for pregnancy.
Our laboratory has identified genes that are enriched in somatic follicular cells and luteal
cells through gene expression microarray. This work was the first to compare the gene
expression profiles of the four somatic cell types involved in the follicle-to-luteal transition
and to support previous immunofluorescence data indicating theca cells differentiate into
SLCswhile granulosa cells become LLCs. Using these data and incorporating knowledge
about the ways in which luteinization can go awry, we can extrapolate the impact that
alterations in the theca and granulosa cell gene expression profiles and lineages could
have on the formation and function of the corpus luteum. While interactions with other
cell types such as vascular and immune cells are critical for appropriate corpus luteum
function, we are restricting this review to focus on granulosa, theca, and luteal cells and
how perturbations such as androgen excess and inflammation may affect their function
and fertility.
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INTRODUCTION TO THE DEVELOPMENT
AND FUNCTION OF THE OVARY
The ovarian follicle is the structural and functional unit of
the mammalian ovary (1–3), which provides the necessary
environment for oocyte growth and maturation (1, 3). The
corpus luteum, which is derived from the somatic cells of a
follicle after the oocyte has been released during ovulation, is a
crucial part of pregnancy. Any defects in ovarian function have a
negative effect on female reproductive health and fertility (4). In
order to fully understand the development of an ovarian follicle
and the subsequent formation of the corpus luteum (CL), it is
helpful to know the origins of the cells of the ovary. Much of
the information provided in this review is based on observations
from studies in the bovine with references to human and mouse
ovarian development.
Ovarian Development
The assembly of ovarian follicles is the developmental process
that mediates the formation of primordial follicles containing
an individual oocyte (3, 5–7). Oocytes originate as primordial
germ cells (PGC) from the endoderm of the embryonic sac
(3, 7). The PGCs migrate by amoeboid movement from the
epithelium of the yolk sac into the hindgut and arrive at the
gonadal ridges (undifferentiated gonads) (3, 8–10). The PGCs
undergo a limited number of mitotic divisions during their
passage and upon arrival at the gonadal ridge (10). The gonadal
ridges develop as a thickening of the coelomic epithelium on
the mesonephros (temporary embryonic kidneys) and make
connections with mesonephric tissue by streams of cells called
rete-ovarii (3). When PGCs migrate they form oogonial clusters
or cysts within the gonadal ridge (6, 11, 12). Mitosis of the
oogonia peaks and then ceases during embryonic development,
and that early population boom determines the number of germ
cells available to all female mammals. Subsequently, the oogonia
enter meiosis (8). Following initiation of the meiotic process,
the oogonial germ cells enlarge (10) (mice). The meiotic process
then leads the oogonial clusters or cysts to break apart to become
oocytes surrounded by a single layer of squamous pre-granulosa
cells to form primordial follicles (6, 8, 11, 13) (mice and bovine)
which establish the ovarian reserve.
Follicle Maturation
The initiation of follicle growth involves the transition of
the primordial follicle from the quiescent follicle pool to the
growing pool (transitional, primary, secondary, and tertiary)
(11, 14, 15) (Figure 1). Morphological changes in granulosa from
squamous/flattened (less differentiated) to cuboidal epithelial
granulosa cells are the histological evidence for the transition
from primordial to primary follicles (16, 17) (Figure 1). The
growth of an oocyte starts immediately after the activation of the
primordial follicle. Further, Braw-Tal and Yossefi (16) reported as
the number of granulosa cells layers around the oocyte increased
there was a corresponding enlargement of the size of oocyte.
The cuboidal granulosa cells in the primary follicle then
start to proliferate, transitioning to a secondary follicle which is
characterized by multiple layers of granulosa cells surrounding
an oocyte (18, 19) (Figure 1). When multiple granulosa cell
layers have formed in the mammalian ovary, a layer of theca
cells differentiate to surround the granulosa cells outside of the
basement membrane (14). This layer of theca cells will eventually
become two distinct types of theca cells, the inner theca interna
and the outer theca externa. The theca interna is a layer of
highly vascularized steroidogenic cells, while the theca externa is
a loosely organized band of non-steroidogenic cells (20).
Finally, a tertiary (or antral) follicle is formed and is
characterized by the presence of a fluid-filled cavity known as
an antrum (18, 19) (Figure 1). The mural granulosa cells that
line the wall of the follicle are critical for steroidogenesis and
ovulation; while cumulus granulosa cells surround the oocyte and
promote its growth and development (18). Greater numbers of
antral follicles present in the ovary are indicative of increased
ovarian reserve and are associated with increased fertility in
heifers (21).
As an antrum forms, tertiary follicles continue to grow and
develop multiple granulosa and theca cell layers (Figure 1).
The granulosa and theca cells are a site of action for the
gonadotropins and a site for production of steroid hormones
(22). An increase in gonadotropin releasing hormone from
the hypothalamus stimulates gonadotropin release from the
pituitary, which promotes follicular growth and estrogen (E2)
secretion from the ovaries (23).
Follicle Waves and Ovulation
Receptors for the gonadotropin follicle stimulating hormone
(FSH) are localized in the granulosa cells of growing follicles
(19, 24). An increase in FSH concentrations during the follicular
phase of the reproductive cycle is very important for the
development of follicular waves (2–3 waves in cattle and
humans), the formation of antral follicles, and the selection of
a dominant follicle (the only follicle that keeps growing while
other follicles regress and undergo atresia) (25, 26) (Figure 1).
The dominant follicle grows faster than the rest of the cohort, is
more sensitive to FSH, and produces higher levels of estrogen and
the regulatory hormone inhibin (2, 19, 27) (Figure 1).
Inhibin and estrogen concentrations in the follicular fluid
of the dominant follicle have a direct negative feedback
effect on FSH release at the anterior pituitary during the
mid-follicular phase (2, 19, 28). The granulosa cells of the
dominant follicle ultimately acquire LH receptors, a hallmark
of a preovulatory follicle (Figure 1). Furthermore, increased
follicular estradiol production stimulates (Figure 1) secretion
of the pituitary gonadotropin luteinizing hormone (LH) and
eventually induces the LH surge (18, 23). When FSH decreases
and LH pulse frequency increases, the dominant follicle becomes
more sensitive to LH receptors (LH/CGR) located in both the
granulosa and theca cells (19). The LH surge is important in the
final maturation and ovulation (follicle rupture) of the dominant
follicle (18, 28), as well as in the terminal differentiation of the
remaining granulosa and theca cells to form the corpus luteum.
The corpus luteum is a transient endocrine structure responsible
for secreting progesterone, which is required for preparing the
uterus for implantation and maintenance of pregnancy (18).
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FIGURE 1 | Process of follicle progression from primordial, primary, secondary, and antral follicles through gonadotropin independent, gonadotropin sensitive, and
gonadotropin dependent phases to ovulation, development of a persistent follicle, follicular atresia and formation of corpus luteum. Expression of growth factors,
hormone receptor genes, and steroids and steroid receptors during each stage of folliculogenesis. The gene expression is representative of the whole follicle or corpus
luteum contribution and not individual cells. Furthermore, the size of the arrows at the beginning are not relative to each gene above or below but relative to the
horizontal changes through the follicle stages and formation of the corpus luteum.
Corpus Luteum Formation and Function
After ovulation, the somatic cells (theca and granulosa)
differentiate into the small luteal cells (SLC) and large luteal
cells (LLC), respectively. The development of the corpus luteum
into an operational endocrine gland involves growth and
development of the steroidogenic cells. Optimal function of
the corpus luteum requires the development of an extensive
capillary network to deliver nutrients for the production
and secretion of the large amounts of progesterone required
to preserve pregnancy in most mammalian species. There
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are different morphological, physiological, and biochemical
characteristics of large and small luteal cells which may reflect
different follicular lineages with separate embryological origins
(3, 4, 29, 30).
Bovine, ovine and human corpora lutea have two distinct
steroidogenic cells with different abilities to produce
progesterone (31). During differentiation, both luteal cell
types acquire high levels of the key enzymes cholesterol side-
chain cleavage P450 (Cytochrome P450 family 11 subfamily
A1 or CYP11A1) and 3β-hydroxysteroid-dehydrogenase (3β-
HSD or HSD3B) that are required to convert cholesterol into
pregnenolone and then progesterone, respectively (32). The
activity of these enzymes appears to be present in excess amounts
in both small and LLC and does not appear to rate-limiting.
The limiting step appears to be the delivery of cholesterol to
mitochondria within each cell. The SLC respond to LH with large
increases in progesterone secretion, and LLC have an elevated
basal rate of progesterone secretion and respond to LH with a
modest increase.
The luteal cells of women, monkeys, and rodents have
variable responses to LH (30) which may be based on their
lipid droplet morphology. Bovine (33) and ovine (34) SLC have
larger lipid droplets and the LLC have abundant, dispersed
small lipid droplets. The cellular origin of the large luteal
cell has generally been ascribed to the granulosa cells in both
ruminants and primates. Luteinization of granulosa cells gives
rise to cells with cellular features and mRNA expression that
are similar to the large luteal cell, whereas luteinization of
theca cells gives rise to cells with features like the small luteal
cell (35, 36). The origin of the two cell types is observed in
the primate based on morphological evidence demonstrating
portions of the corpus luteum that are primarily granulosa-lutein
cells and other areas that primarily contain smaller theca-lutein
cells (37).
LINEAGE SPECIFICATION OF
GRANULOSA AND THECA CELLS
Granulosa Cell Lineage
Granulosa cells are interesting in that they are not a uniform
population of cells. Some granulosa cells have properties of stem
cells including the ability to divide and form colonies (38), divide
without contact inhibition (39), and may share properties of
endothelial cells (40). All of these may be different depending
on the species of reference. During the development of the
ovary, granulosa cells may originate from several cell types
(Figure 2). Early researchers provided evidence that murine
granulosa cells developed from both the coelomic epithelium
that forms the ovary as well as cells that migrated in from the
mesonephros (43, 44). With the advent of conditional knockout
mice and fluorescent tags, many of the cell lineages have been
refined in the mouse model with further cell lineage differences
determined in larger mammals (4, 36). The multiple cellular
origins of granulosa cells (where they originate- see Figures 2,
3) may result in altered function and differentiation of these
cells later during follicle formation (Figure 2) which would
affect subsequent corpus luteum development and function
upon ovulation. For instance, pregranulosa cells in the bovine
(and potentially ovine and human) are derived from gonadal-
ridge epithelial-like (GREL) cells. Also stem cells are derived
from GREL cells. It is not known if stem cells can also form
granulosa cells or different populations of granulosa cells such
as mural and cumulus cells. Environmental factors can affect
the GREL cells, which may determine if they produce stem cells
or pregranulosa cells (3). If the ovarian environment fluctuates
based on alterations in cytokines, growth factors, gonadotropins,
or steroids it is possible that these granulosa cells might
differentiate into populations with different gene expression
profiles and function. Thus, further differentiation (luteinization)
FIGURE 2 | Schematic diagram illustrating the potential and known granulosa and theca cells lineages in the mice, human, bovine, and ovine ovaries and how they
interact for follicle development. Somatic progenitor cells have origins from the developing coelomic gonadal epithelium and mesonephric cells. This figure was
developed from information in Hummitzsch et al. (3, 41) and Rotgers et al. (42).
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FIGURE 3 | Genes enriched in granulosa cells, theca cells, large luteal cells (LLC), and small luteal cells (SLC). Enriched genes are involved in processes related to
signaling, adhesion, extracellular matrix, steroidogenesis, transport, or are unknown. Interestingly, it appears that the categories change from somatic to luteal cells
with mainly genes involved in signal transduction enriched in LLC and more adhesion or extracellular matrix genes enriched in SLC. Tables of these enriched genes are
in Romereim et al. (36).
of these granulosa cells following ovulation may alter the luteal
phenotype and also affect production of progesterone and the
ability to maintain pregnancy.
The granulosa cells in mice originate from somatic progenitor
cells that come from the coelomic epithelium of the gonad
(4, 45, 46). These somatic progenitor cells commit to either pre-
granulosa cells or stromal progenitor cells (Figure 2) (4, 46).
The pregranulosa cells may have different functions and some
may not proliferate depending on whether they are medullary
or cortical. The medullary cells develop in the initial waves of
pregranulosa differentiation and then migrate to and become
part of the medullary follicles. In a second wave of pregranulosa
cell differentiation, the cortical follicles develop and expand
to become the ovarian reserve. A review on these different
medullary vs. cortical follicles and the specific markers that
differentiate them are presented in detail below (42).
In mice, cortical and medullary granulosa cells (Figure 2)
commit to different types of pregranulosa cells depending on
expression of specific genes. Medullary granulosa cells express
the markers Gata4+/Cdkn1b+, while cortical pregranulosa cells
express Gata4+/Lgr5+. The receptor for RESPO1, LGR5, is
responsible for continuing development of these granulosa cells.
At later stages, the cortical granulosa cells acquire Cdkn1b+,
and as mature cells both cortical and medullary granulosa cells
express FoxL2, which is critical for maintaining their granulosa-
like phenotype. Without FoxL2 these granulosa cells could revert
to a testis (Sertoli-like) or epithelial lineage and express Sox9;
this also occurs in some granulosa cell tumors (47). Expression
of FoxL2 is dependent on estrogen; thus, steroid environments
lacking adequate estrogen may also affect granulosa cell function,
proliferation, and development (42).
In larger mammals, the main body of evidence indicates that
granulosa cells originate from the mesonephric surface epithelial
cells (the temporary embryonic kidney) (Figure 2) such as in
humans (42) and bovine (3, 41). Mesonephric surface epithelial-
like cells break down to form GREL cells that differentiate into
pre-granulosa cells and stem cells. The pre-granulosa cells then
differentiate into granulosa cells. It is not known if the stem cell
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population in addition to self-renewal can also form a population
of granulosa cells or other cell types in the ovary (Figure 2).
GREL cells appear to be located above the mesonephric surface
epithelium or to break into this layer and to expand. Thus, the
GREL cells may also be contributing to surface epithelial cells,
which repair wounds that occur due to ovulation (3, 41, 42, 45,
46). In larger species such as bovine, the pre-granulosa cells also
form granulosa “stem” cells which can differentiate into cumulus
and mural granulosa cells. The mural granulosa cells are the
cell type that later will luteinize into the LLCs because they are
the only granulosa cells expressing the LH receptor. Constant
communication between granulosa cells and their surrounding
environment allows for differentiation, gene expression, growth
factor secretion, and cell fate (42).
Theca Cell Lineage
There are many important roles for theca cells in the
follicle including crosstalk with granulosa cells for synthesis of
androgens and estrogens, as well as providing structural support
of the growing follicle as it progresses through the developmental
stages to produce a mature and fertilizable oocyte (42, 48).
The origins of theca cells have not been definitively identified
(4). Some investigators hypothesize that theca cells come from
mesonephric cells in mice, humans, and bovine (3, 4, 42, 45, 48,
49) (Figure 2).
Other investigators have suggested that theca cells in the
mouse originate from the stratified medial aspect of the
mesonephric kidney, as they have observed cells with elongated
nuclei and an overall appearance of fibroblasts (45, 46). In
more recent mouse studies using fluorescent tags to Wt1 (WT1
transcription factor) and Gli1 (GLI Family Zinc Finger 1) genes,
investigators reported that theca cells come from two sources
including ovary-derived Wt1+ cells and mesonephros-derived
Gli1+ cells (4). The expression of Gli1 in theca progenitor
cells is induced by the paracrine signals Desert hedgehog (Dhh)
and Indian hedgehog (Ihh) from granulosa cells (4). Moreover,
Growth differentiation factor 9 (GDF9) from the oocyte induces
Dhh/Ihh in granulosa cells (4). In the absence of Dhh and Ihh,
ovaries have reduced layers of theca cells around the follicle,
decreased steroid production, disrupted folliculogenesis, and fail
to form corpora lutea (4). Thus, the recruitment of theca cells
from the stroma is regulated by factor(s) produced by granulosa
cells at the primary and secondary follicle stages (4, 50).
A previous study in women also demonstrated that theca
cells originate from the coelomic epithelium of the gonadal
primordium and the neighboring mesonephros under paracrine
regulation from granulosa cells (51). Other studies, including
those in the bovine, demonstrated that theca cells are recruited
from surrounding stromal tissue by factors secreted from an
activated primary follicle (3, 41, 49) (Figure 2). The actual
factors have not been fully identified, but granulosa and oocyte
interactions with stroma may cause stroma cells to differentiate
into theca cells. It has been proposed that stroma stem cell niches
exist in mice, human, and bovine ovaries that allow multiple cell
types to be developed depending on the growth factors present
(3, 4, 42, 48, 49, 52). Large areas of the ovary including groups
of stromal cells surrounding some large blood vessels stain
positively for chondroitin/dermatan sulfate epitopes (antibodies
7D4, 3C5, and 4C3) similar to stem cell niches observed in
other tissues. These stromal cells may therefore represent a stem
cell niche (52). Another study suggested that thecal stem cells
are present in mouse ovaries (49). However, these data require
further support including determination of whether all the cells
or only a proportion of the cells in these stem-cell colonies
express genes in the Dhh/Ihh pathway such as Ptch1 and 2, Gli
2 and 3 (49), which would suggest a theca stem cell lineage.
THE STEROIDOGENESIS TIMELINE AND
PATHWAYS IN GRANULOSA AND THECA
CELLS
The granulosa and theca cells are a site of action for the
gonadotropins (hormones secreted by the pituitary gland that act
on the gonads) and a site for production of steroid hormones (22,
27, 53). Steroid hormone secretion by ovarian tissues is tightly
regulated and crucial to the coordination of reproductive cyclicity
(29). Steroidogenesis is the process involving the conversion of
cholesterol to androgens, estradiol, and progesterone through a
variety of steroid hormone intermediates (54, 55). The enzymes
and series of intermediates used in humans and ruminants are
collectively called the 15 pathway; whereas steroidogenesis in
rodent and pig ovaries can occur through either the15 or the14
pathway (24). Granulosa cells and theca cells must act together
for ovarian steroidogenesis. The first evidence of both theca and
granulosa cells interacting to produce estradiol was reported by
Falck (56) indicating estradiol production in rat follicles required
both cell types. Ovarian steroid production is critical for normal
ovarian processes including follicle growth, differentiation,
oocyte maturation, and ovulation (57–59). Ovarian steroids are
also required for the normal function and development of several
tissues in the female including the uterus, breasts, skeleton, and
others (54, 55, 57).
Steroidogenesis in the Developing Ovary
The timing of steroidogenesis in the theca and granulosa
cells begins surprisingly early in development. Cells within
the mammalian fetal ovary already express steroidogenic
enzymes and receptors and have the potential to produce
both estrogen and progesterone (60–65). However, because
estrogen and progesterone have been demonstrated to inhibit
primordial follicle activation (5, 63, 66) and progesterone inhibits
follicle assembly in vitro (7, 67), ovarian factors must inhibit
steroidogenesis to allow these developmental events to occur.
Production of estrogen and progesterone by the fetal ovary
occurs early in development until the formation of germ cell
cords, and then steroidogenesis is inhibited to allow follicle
formation/assembly and development of the ovarian reserve (7,
63, 68).
A recent study by da Silva (69) demonstrates that fibroblast
growth factor 18 (FGF18) produced by ovigerous cords in the
fetal bovine ovary may inhibit production of estrogen during
this early development period. FGF18 expression increases at the
time when fetal ovarian estrogen and progesterone are declining,
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which occurs around the time of follicle assembly. Interestingly,
treatment of cultures bovine fetal ovarian explants with
FGF18 inhibits production of CYP19A1 and CYP11A1, causing
reductions in secretion of both estrogen and progesterone in vitro
(69). Thus, steroid production occurs early in the ovary from the
ovigerous cords, which later become oogonial clusters or cysts;
and FGF18 may be a paracrine growth factor that allows for both
follicle development and granulosa/theca cell differentiation.
Steroidogenesis During Follicle Maturation
and Regulation by Gonadotropins
For estrogen synthesis to occur, cholesterol must first be
converted to androgen in theca cells through actions of
luteinizing hormone (LH), and androgens are further converted
in granulosa cells to estrogens via follicle stimulating hormone
(FSH) (27, 57–59) (Figure 1). In general, the binding of LH to
its receptors on theca cells leads to the conversion of cholesterol
into androgens like androstenedione; the androgens then diffuse
into the granulosa cells to be converted to estrogens like estradiol
by aromatase activity under the regulation of FSH (27, 58)
(Figure 1). More specific descriptions of each step of the pathway
detailing the enzymes and steroid intermediates involved are
described below.
Theca cell formation occurs when a maturing follicle contains
two or more layers of granulosa cells and coincides with the
follicle becoming responsive to LH (48, 70) (Figure 1). Binding
of LH to its receptor (LHCGR) on theca interna cells leads
to signal transduction via G protein-coupled receptors (Gαs).
Activation of Gαs, in turn, stimulates adenylyl cyclase, leading
to an elevation in intracellular cAMP levels and subsequent
activation of protein kinase A (PKA) (71). This elevation in
cAMP and PKA activity promotes steroidogenesis by increasing
expression of steroidogenic acute regulatory protein (STAR) as
well as by increasing STAR activity via phosphorylation on
serine 195 (71). Cholesterol is transported from the cytosol
into the inner mitochondrial membrane by STAR in theca cells
(57, 72, 73). The movement of cholesterol from the outer to
the inner mitochondrial membrane by STAR is believed to be a
rate-limiting step in gonadal and adrenal tissues (55, 57, 72).
The granulosa cell expresses receptors for FSH (27, 57).
The binding of FSH to its receptor leads to an increase in
intracellular cAMP levels and subsequent activation of several
pathways including protein mitogen-activated protein kinases
(p42/p44 MAPK and p38-MAPK) and phosphatidylinositol 3-
kinase (PI3K), which regulate many FSH target genes such as
the steroidogenic enzyme CYP11A1 and STAR. In addition,
PKA is activated and stimulates the phosphorylation of other
regulatory proteins (CREB, β-catenin, AKT, MKP3/DUSP6,
p42/44MAPK, GSK-3ß, FOXO1, and YAP) involved in granulosa
cell differentiation and steroidogenesis (27, 74–79).
The timing and magnitude of the expression of genes
important to the steroidogenic process is dynamic and controlled
by follicle maturation. Expression of STAR, CYP11A1, CYP17A1,
and HSD3B, and LHCGR mRNA is present in preantral follicles
(80, 81). Furthermore, expression of these steroidogenic enzymes
in theca cells increases as antral follicle growth continues (81).
Similar to theca cell steroidogenic mRNA expression, abundance
of steroidogenic enzymes in the granulosa cells (P450 aromatase
and 17β-HSD) increases as follicles progress from small to large
antral stages (80). As follicles mature and near ovulation, large
quantities of LH actually decrease the enzymatic activity that
promotes estrogen production and instead increase enzymatic
activity promoting progesterone production (24) (Figure 1).
Thus, conversion of cholesterol to androgens resulting in
estrogen requires specific cells types and enzymes within the
somatic compartment in the follicle. If these enzymes are over-
expressed or not expressed, then this may lead to many different
disorders. Excess androgen production is a criterion used to
diagnose women with polycystic ovary syndrome (PCOS) (15),
a metabolic and reproductive disorder. While the etiology of
the PCOS phenotype is not completely known, inappropriate
regulation of steroid enzymes or differentiation of somatic cells
and inflammation may contribute to this disorder.
GENES EXPRESSED AND ENRICHED IN
FOLLICULAR SOMATIC CELLS AND MAY
BE MARKERS FOR THECA AND
GRANULOSA CELLS
Several genes enriched in the granulosa cell transcriptome
were identified as granulosa cell gene markers when compared
to theca, LLCs, and SLCs including signaling molecules:
Adhesion G Protein Coupled Receptor B3 (ADGRB3), Ephrin-A5
(EFNA5), PREDICTED-Protein Tyrosine Phosphatase receptor
Type T (PTPRT), Regulator of G-Protein signaling 17 (RGS17),
and Follicle Stimulating hormone receptor (FSHR) (Figure 3).
Additional genes enriched in granulosa cells are involved in
cell adhesion and extracellular matrix: Cadherin 12 (CDH12),
and Heparanase (HPSE); and steroidogenesis: Cytochrome P450
family 19 subfamily A polypeptide 1 (CYP19A1), the critical
enzyme activated by downstream signaling of FSHR to elicit
conversion of androgens to estrogen (36, 82). There were also
many effector molecules upregulated specifically in granulosa
cells related to cell proliferation, survival, DNA replication and
repair, and microtubule/chromosome rearrangement including
SMADs, PLC, kinases involved in signaling cascades like
MAPK3K5, and especially G-protein signaling modulators (36).
Moreover, granulosa cells have their own gene expression
patterns related to cell functions: cell cycle progression (genes
involved in S phase and G2 phase), cellular colony formation
(related to proliferation and cellular adhesion), RNA decay,
functions associated with G protein and tyrosine kinase
receptors, and genes related to FSH signaling protein complex
assembly (36).
Genes enriched in theca cells that may be used as
markers are genes involved in signaling: Platelet-derived growth
factor receptor, alpha polypeptide (PDGFRA); cell adhesion or
extracellular matrix development: actin gamma 2 (ACTG2),
A disintegrin and metalloprotease domain-like decysin 1
(ADAMDEC1), Collagen type I alpha 2 chain (COL1A2),
Lysyl Oxidase like 1 (LOXL1), Osteomodulin (OMD), Claudin
11 (CLDN11), and steroidogenesis: Cytochrome P450 Family
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17 Subfamily A Member 1 (CYP17A1) (36, 82) (Figure 3).
Theca cells have increased gene expression patterns related
to metabolism, glycolysis, oxidation of proteins, metabolism
of heme, synthesis of carbohydrates, synthesis of sterols, and
increased gene expression related to extracellular matrix genes
such as decorin, collagens, elastin, and fibrillin (36). Interestingly,
in women diagnosed with PCOS, there is a thickening of
the cortex of the ovary, which may suggest upregulation of
extracellular matrix proteins (83). These ovaries also are more
rigid. One of the genes associated with theca cells, fibrillin 3, is a
glycoprotein that is associated with the extracellular matrix, and
its overexpression may also be linked to the rigid nature of these
PCOS ovaries (84).
Genes enriched in granulosa cells vs. theca are mainly those
regulating signaling and proliferation of cells in the follicular
compartment (36). Furthermore, the expression of FSHR is
specific to granulosa and not theca whereas LHGCR or LH is
expressed in both theca and granulosa cells (85). Theca cells are
enriched in genes that are involved in extracellular matrix and
cell adhesion, suggesting theca cells have a more mesenchymal
phenotype with more genes regulating stromal composition.
Both somatic cells expressed a cell type-specific enzyme that
regulates steroidogenesis (CYP19A1 and CYP17A1 in granulosa
and theca cells, respectively).
MORPHOLOGICAL CHANGES TO
FOLLICULAR SOMATIC CELLS AFTER
OVULATION AND LUTEINIZATION
At ovulation, the antral follicle undergoes a remarkable
transformation. The somatic follicular cells (theca and granulosa)
luteinize into a bloody structure called a corpus hemorrhagicum,
which then undergoes maturation to a highly vascularized corpus
luteum (86) (Figures 1, 3). In the bovine, the luteinization
process starts as granulosa cells and theca interna cells begin to
differentiate into large and small luteal cells, respectively (3, 31,
36, 87) (Figures 1, 3). Small and large luteal cells are referred to as
parenchymal cells that, together with fibroblasts and endothelial
cells, form the basic structure of the corpus luteum (88, 89).
Recently, we reported that bovine small and large luteal cell types
are highly similar based on overall gene expression profiles, with
some notable differences (36). A subsequent report evaluating the
differences in gene expression in SLCs and LLCs in bovine corpus
luteum confirmed these findings (90).
Both SLCs and LLCs possess LH receptors and synthesize
and secrete progesterone (36) (Figure 1). Although SLCs are
highly responsive to LH, large luteal cells are responsible for
80% of the total progesterone produced by the corpus luteum
(91). As the corpus luteum matures, it is proposed that SLCs
can increase in number but not in size, whereas large luteal
cells can increase in size but not in number during the normal
estrous cycle (89). Studies have shown that appropriate numbers
of granulosa cells in the developing follicle are critical to
provide the minimum population of LLCs needed to maintain
progesterone production (92). Environmental factors that affect
the proliferation or fate of granulosa cells may reduce luteal cell
numbers with adverse effects on progesterone production by the
subsequent corpus luteum.
Progesterone targets many tissues, including the
hypothalamic-pituitary axis, ovary, oviduct, uterus, cervix,
vagina, and mammary gland and embryo (29). Luteal
progesterone secretion serves as a local luteal cell survival
factor (93), regulates the length of the estrous cycle, and is
essential for maintenance of pregnancy (29, 36). Progesterone
also regulates the timing of ovulation in livestock species (94).
When fertilization of the oocyte and implantation are successful,
maternal recognition of pregnancy results in the maintenance
of the corpus luteum, which ensures pregnancy maintenance
and embryo development (36, 95). Otherwise, the luteolytic
cascade would be initiated with the release of prostaglandin F2α
in a pulsatile pattern, causing regression of the corpus luteum
(36, 95). Anti-luteolytic mechanisms such as secretion of IFNT
signaling molecules from the conceptus result in gene expression
changes in the LLC and SLC such as increasing expression
of ISG15 (interferon-stimulated gene, 15 kDa) (95, 96). Thus,
ovarian somatic cells play an essential role in embryonic fate (96).
CHANGES IN GENE EXPRESSION IN
THECA AND GRANULOSA CELLS DURING
DIFFERENTIATION TO SLCs AND LLCs
The process of luteinization is a dramatic change in the
morphology and function of the follicle. This process is initiated
by the surge of LH at the time of ovulation. Specific alterations
in gene expression occur in theca cells responding to the
LH surge that are compatible with a transition to a SLC
phenotype including a decrease in expression of CYP17A1,
Solute carrier family 1 member 3 (SLC1A3), TNF receptor-
associated factor 5 (TRAF5), Tetraspanin 33 (TSPAN33), and
Hydroxyprostaglandin dehydrogenase (HPGD) concurrent with
increased expression of Ras homolog family member B (RHOB)
(36, 97). There are also alterations in granulosa cell gene
expression in response to the LH surge that are compatible
with a transition to an LLC phenotype including loss of
GC expression of Cytochrome P450 family 19 subfamily A
member 1 (CYP19A1),Carbohydrate sulfotransferase 8 (CHST8),
Hydroxysteroid 17B dehydrogenase 1 (HSD17B1), Glutamate
cysteine ligase catalytic subunit (GCLC), Solute carrier family
35 member G1 (SLC35G1), and Alanine amino transferase or
Glutamic-pyruvate transaminase) (GPT) along with the gain
of expression of Pentrax 3 (PTX3), Runt-related transcription
factor 2 (RUNX2), periostin (POSTN), Rho-related GTP-binding
protein (RND3), tissue inhibitor of metalloprotease 1 (TIMP1),
Neurotensin (NTS), Fos proto-oncogene (FOS), and regulator
of calcineurin 1 (RCAN1) (36, 97) (Figure 3). These differences
in expression of genes also characterize granulosa cells moving
from an epithelial cell type to a mesenchymal phenotype as
well as a steroidogenesis transition from androgen-centric and
estrogen-centric to a progesterone-centric machine, allowing for
the production of large quantities of progesterone necessary to
support establishment and maintenance of pregnancy.
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LUTEAL CELL ENRICHED GENES THAT
CAN BE USED AS MARKERS FOR LLCs
OR SLCs
In addition to its function as a steroidogenic powerhouse,
comparisons of gene expression profiles among granulosa,
theca and luteal cells, and bioinformatics analysis predicts
that a primary function of the LLC is adhesion (binding of
cells, growth of epithelial tissue, and quantity of connective
tissue) which is consistent with the changes that occur during
luteal formation and LLC differentiation (36). Ultrastructural
studies clearly demonstrate that bovine LLCs are closely
associated with endothelial cells and have a vast surface
area of cellular processes that connect with those cells
(98), presumptively providing for adequate nutrition and
substrates for progesterone production and easy access for
progesterone to enter the blood stream. Genes related to cell
signaling were enriched in LLCs including receptors such
as Prostaglandin E Receptor 3 (PTGER3), Platelet-derived
growth factor receptors (PDGFR), Prolactin receptor (PRLR),
Fms related tyrosine kinase 1 (FLT1), kinase insert domain
receptor (KDR), adrenergic receptor (ADRA2B), endothelin
receptor (EDNRB), Transforming growth factor-beta receptor
type 2 (TGFBR2), and TNF receptor superfamily member 21
(TNFRSF21) (36) (Figure 3). Moreover, the LLC is enriched
with genes coding for secreted signaling molecules including
Platelet derived growth factor subunit A (PDGFA), Parathyroid
Hormone Like Hormone (PTHLH), Angiogenin (ANG), G
protein-coupled receptor 183 (GPR183), Prostate androgen-
regulated mucin-like protein 1 (PARM1), Prostaglandin
F receptor (PTGFR), and RAS guanyl releasing protein 1
(RASGPR1) (Figure 3), genes for angiogenesis including
Ephrin-B2 (EFNB2), Platelet-derived growth factor receptor
beta (PDGFRB), and Vascular Endothelial Growth Factor A
(VEGFA), genes for differentiation of cells including Neurogenic
Locus Notch Homolog Protein 3 (NOTCH3), Parathyroid
Hormone Like Hormone (PTHLH), Transforming Growth
Factor-beta receptor type 2 (TGFBR2), and WNT11, genes for
immune and inflammatory responses (chemokines, interleukins,
tumor necrosis factor family molecules), genes for synthesis
of lipids including Acyl-CoA Oxidase 2 (ACOX2), Acyl-CoA
Synthetase Long Chain Family Member 4 (ACSL4), Cytochrome
P450 Family 7 Subfamily B Member 1 (CYP7B1), Retinol
Dehydrogenase 10 (RDH10), and genes related to ion transport
including Solute Carrier Family 7 Member 8 (SLC7A8),
ATPase Na+/K+ transporting subunit beta 2 (ATP1B2)
(36). Thus, many changes occur in LLC gene expression
during differentiation that aid in developing vasculature,
regulation of immune cell interactions, and maintenance of
progesterone production.
In contrast, as determined by genes specifically enriched
in SLCs, bioinformatics revealed their primary function as
metabolism, including metabolism of phospholipids, peptides,
and sterols as well as regulation of the concentration of
ATP (36). Genes enriched in SLCs are signaling molecules
including Luteinizing hormone receptor (LHCGR), Pim-1 Proto-
Oncogene (PIM1). SLCs also had three genes enriched involved
in adhesion and extracellular matrix including Collagen and
Calcium binding EGF (CCBE1), Claudin 1 (CLDN1), Coxsackie
virus and adenovirus receptor (CXADR); and Syntaxin 11
(STX11) is involved in transport while Peptidase domain
containing associated with muscle regeneration 1 (PAMR1) gene
function is unknown (36) (Figure 3). When comparing SLC
gene expression to that of LLCs, theca cells, and granulosa
cells, SLCs had the greatest number of genes involved in signal
transduction including the following: both receptors and ligands
related to BMP signaling, complement components involved in
immune response, and effector molecules such as kinases and
phospholipases (36).
INFLAMMATION CAN AFFECT
GRANULOSA AND THECA CELLS WHICH
MAY PERTURB CORPUS LUTEUM
FORMATION AND FUNCTION
Ovulation is similar to an inflammatory cytokine-mediated
response (99, 100) and is associated with an increase in
vasodilation, production of prostaglandin, cell proliferation, and
secretion of tissue as well as local growth regulatory factors (101,
102). Some studies have suggested that the innate immune system
is active in connection with ovulation (101–103). Cytokines are
both key modulators of the immune system and contribute
to regulation of the ovarian cycle. In fact, the expression and
function of innate immune cell-related genes in non-immune
cells within the ovary has been reported and provides a novel and
important regulatory system during ovulation (104).
Cytokines and chemokines play an important role in ovarian
function and follicular development throughout the estrous
cycle. One study in early antral follicles (22) found 446 genes
in granulosa cells and 248 genes in theca cells, with only 28
regulated genes that were common to granulosa and theca
cells. These shared genes were associated with bovine antral
follicle development, and they have identified candidate growth
factors and cytokines potentially involved in inflammation
and cell–cell interactions required for ovarian function such
as the following genes: Macrophage inflammatory protein
(MIP1 beta), Teratocarcinoma-derived growth factor 1 (TDGF1),
Stromal derived growth factor 1 (SDF1; i.e., CXCL12), Growth
differentiation factor 8 (GDF8), Glia maturation factor gamma
(GMFG), Osteopontin (SPP1), Angiopoietin 4 (ANGPT4), and
Chemokine ligands (CCL 2, 3, 5, and 8) (22).
During the latter stages of follicular development, there
is cellular restructuring including follicular wall breakdown,
oocyte expulsion and cellular reorganization in preparation for
ovulation. These processes are initiated by pro-inflammatory
cytokines and chemokines such as interleukin 1α (IL-1α), tumor
necrosis factor alpha (TNFα), and chemokine (C-C motif)
ligand 4 (CCL4) which stimulate migration of macrophages,
monocytes, and leukocytes into the follicle (105). The cytokines
indicated above induce an M1 pro-inflammatory phenotype
in the infiltrating macrophages that secrete these same pro-
inflammatory cytokines, producing a feed-forward mechanism
required for ovulation. In some situations such as persistent
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follicles (i.e., arrested follicles, such as in PCOS), expression of
these pro-inflammatory cytokines is enhanced and may promote
increasedmigration ofmacrophages, neutrophils, andmonocytes
into the dominant follicle to potentially reduce granulosa cell
proliferation, steroidogenesis and subsequent corpus luteum
function (106, 107) (Figure 4). Inflammation and cytokines are
dramatically higher in follicular fluid from follicles of PCOS
patients who are obese (108). In granulosa cells during ovulation,
259 genes were found to be upregulated (2–80-fold) (102). Most
of these genes were involved in cytokine signaling to initiate
inflammation, innate immunity (102, 109), and cell proliferation
factors involved in tissue repair during ovulation (102). The most
prominent pathways that represent several modes of cytokine
signaling in granulosa cells include MAPK and JAK/STAT
signaling (102).
The luteolytic process has also been compared to an
acute inflammatory response since it involves infiltration of
neutrophils (110–113), macrophages (111, 114–117), and T
lymphocytes (111, 115, 116). There is also secretion of cytokines
that recruit and potentially trigger leukocytes to become active
(118–120). PGF2α rapidly induces many cytokine transcripts in
luteal cells (121) such as Tumor necrosis factor alpha (TNF)
(122, 123), Transforming Growth Factor Beta 1 (TGFB1) (123–
125), interleukin 1 beta (IL1B) (122, 126), and chemokines
such as C-C motif chemokine ligand 2 (CCL2) (118, 125, 127)
and C-X-C motif 8 (CXCL8) (112, 113, 123, 125, 126, 128).
These cytokines can inhibit progesterone secretion (129–132)
and stimulate PGF2α secretion (129, 130, 132). These cytokines
can also induce apoptosis in luteal cells (130, 131, 133).
Luteolytic factors secreted by the uterus induce a reduction
in blood flow, recruitment and migration of immune cells,
reduction in progesterone production, and secretion of pro-
inflammatory cytokines within the corpus luteum to induce
regression (134, 135). As the intra-luteal concentrations of
PGF2α and inflammatory cytokines increase, they may act within
an auto-amplification loop until they eventually reach a critical
point from which there is no return from the luteolytic cascade
(121). Much of the research on immune cells has been conducted
in the regressing or late corpus luteum. There is information to
suggest that immune cells, mainly macrophages, are present in
the corpus luteum (136) and that SLCs produce factors which
recruit immune cells (90). Also a recent study demonstrated that
depletion of immune cells prior to ovulation blocks ovulation and
prevents corpus luteum formation (137).
Several papers have shown that cows with persistent or cystic
follicles do have problems ovulating, and women with PCOS
also have chronic inflammation. Thus, the types and numbers
of immune cells in the follicle may alter ovulation and/or
the function and formation of the corpus luteum (Figure 4).
Lymphocytes do migrate into the corpus luteum and regulate
cellular proliferation, steroidogenesis and cell differentiation;
however, much needs to be determined about which specific
cell types (T, B, Natural Killer; NK) these are and how they
might affect any macrophages that are present at the time
of ovulation (136). Poole and Pate concluded that, in bovine
corpus luteum, the microenvironment regulates the recruitment
or differentiation of lymphocyte cells, and these specific
lymphocyte cell types (resident T cell lymphocytes) interact
FIGURE 4 | Proposed pathways where Inflammation/Genetics or Environment may cause altered function of individual cells of the follicle (granulosa, oocyte and
theca) to alter transcription or expression of genes by epigenetic mechanisms resulting in altered cell to cell communication, arrested follicle development, and
anovulation, altered luteal function, and female infertility.
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with steroidogenic cells to promote appropriate progesterone
production and function of the developing corpus luteum.
A microarray analysis comparing SLC and LLCs determined
that gene expression of immune factors were greater in SLCs
compared to LLCs in bovine mid-stage corpus luteum, with
upregulation of chemokines CCL2, CCL3, CCL4, CCL5, CCL8,
andCCL16, and several CXC chemokines as well asCX3CL1. This
may suggest that the theca and SLCs have critical functions in
directing immune cells to the site of luteal formation to either
stabilize its structure, increase progesterone, or enhance vascular
development (90).
PERTURBATIONS IN GENE EXPRESSION
IN GRANULOSA OR THECA CELLS
THROUGH INFLAMMATION AND ALTERED
STEROIDOGENESIS MAY ALTER LLCs OR
SLCs AND IMPAIR LUTEAL FUNCTION
Stressors During Ovarian Development
Inflammation, environmental stressors, abnormal follicular
somatic cell differentiation can result in excess androgens,
follicular arrest, anovulation, persistent follicles, and sub-
functional corpora lutea, all of which may contribute to female
infertility disorders (3, 138) (Figure 4). Since steroidogenesis
occurs in early fetal life, maternal stressors may perturb cell
differentiation of the ovary to alter theca or granulosa cell lineage
differentiation and steroid enzyme expression (60–65). Thus,
excessive androgen production during the formation of the ovary
may affect progenitor cells that give rise to both granulosa
cells and theca cells to change their identity. Furthermore, if
oocytes or granulosa cells do not express appropriate factors,
theca cell differentiation may be altered which may negatively
impact formation of the SLCs (and possibly LLCs through cell-
cell interaction) and adversely affect the formation and function
of the corpus luteum.
Excess Androgens May Affect Follicle
Growth and Proliferation of Granulosa
Cells
Increased amounts of androgen hormones in the follicular
microenvironment are a major factor for follicle arrest (139).
Dehydrotestosterone (DHT) treatment reduces granulosa
cell cycle progression and FSH-stimulated cell proliferation
(140) by decreasing the expression of cell cycle proteins
(141). Additionally, DHT stimulates the expression of tumor
suppressor gene (PTEN) through peroxisome proliferator-
activated receptor gamma (PPARγ) which in turn suppresses
the phosphatidylinositol 3-kinase (PI3K)/AKT signaling
pathway, leading to cell cycle arrest and reducing granulosa cell
proliferation and viability (142). Several researchers (15, 143)
suggest that androgen excess is the most important symptom
in PCOS. Women diagnosed with PCOS may have abnormal
theca cell function and increased androgens, leading to abnormal
ovarian follicular development (15, 144, 145). Excess circulating
androgen is associated with ovarian dysfunction and metabolic
disorders in women (146). Androgenized rats had fewer estrous
cycles and lower numbers of mature and ovulated follicles
(142, 145).
TGFβ Family Perturbations Can Alter
Granulosa Cell Function
Transforming growth factor beta family growth factors have
specific roles in follicle arrest and progression. One TGFβ family
member, Anti-Mullerian growth factor (AMH) is produced by
large dominant follicles (in humans and bovine) and suppresses
other growing follicles until just prior to ovulation (147)
(Figures 1, 4), AMH also inhibits FSH-stimulated functions of
bovine granulosa cells (147). A majority of women diagnosed
with PCOS also have excess granulosa cell production of AMH
and another TGFβ family member, follistatin (FST) (148). The
excess AMH may be caused by genetic variants in the AMH or
AMHR genes (149) or due to oocyte factors (BMP15 and GDF-
9) causing acetylation of histone 3 lysine 27 (H3K27ac) (150)
in granulosa cells to enhance AMH transcription (Figure 4).
Furthermore, AMH inhibits aromatase and reduces estrogen
production, resulting in excess androgens (151, 152). In human
follicles (85) expression of FST is positively correlated with
AMH, FSHR, and AR. Follistatin and its family member FSTL4
are upregulated in LLCs compared to SLCs (90) in the bovine
corpus luteum, suggesting that TGFβ family member secretion
(e.g., FST) by LLCs may continue to regulate developing follicles
for the subsequent cycle. Thus, alterations in AMH and other
TGFβ family members in women diagnosed with PCOS may
also indicate changes in their follicles and subsequent corpus
luteum function.
Altered Follicular Development and
Subsequent Luteal Function
The development and regression of the corpus luteum in
ovulatory women with polycystic ovaries have been studied
and compared with normally cycling women, and the corpora
lutea exhibited no morphological or degenerative differences
(153). However, in women with sporadic or chronic anovulation,
there is reduced progesterone throughout the menstrual cycle
(154) suggesting there is potential for altered luteal function.
(155). Additionally, cows with persistent follicles have been
demonstrated to develop sub-functional corpus luteum which
cannot maintain a pregnancy (156). In androgenized sheep
models, the development of PCOS-like phenotypes also results
in luteal dysfunction resulting in early pregnancy failure
(12). Thus, many facets of luteal function need to be
evaluated, including abnormal follicular somatic cell lineage
differentiation, to determine how therapies may be employed
to maintain progesterone production and promote appropriate
luteal formation in mammals.
In summary, anovulation is the leading reproductive disorder
in mammalian females. Understanding what affects the ovulation
process in order to cause anovulation is essential to improve
female fertility. The formation of a functional corpus luteum
relies on the appropriate proliferation and differentiation of
both granulosa and theca cells. Any disruption in the crosstalk
between granulosa and theca cell or differentiation of these cells
types alters lineages and gene expression profiles that could
negatively impact luteinization and progesterone production.
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Moreover, there are a number of autocrine and paracrine
factors can affect the formation of the corpus luteum, e.g.,
growth factors, androgen excess, and inflammatory cytokines
as discussed within this review. We hope that this review will
spark interest and research to better understand the complex and
fascinating processes used during the formation and regression
of the corpus luteum.
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